Understanding Medulloblastoma

Medulloblastoma is a malignant tumor that arises in the cerebellum or the brainstem, most commonly in the posterior fossa of the brain. It is one of the most frequent malignant brain tumors in children, though it can also occur in adults. These tumors are highly cellular and tend to spread through the cerebrospinal fluid pathways, making early recognition and treatment essential. Common symptoms include headache, nausea, vomiting, unsteady gait, and increased intracranial pressure.

The Role of MRI in Diagnosing Medulloblastoma

Magnetic resonance imaging (MRI) is the gold standard for evaluating suspected brain tumors, including medulloblastoma. On MRI, medulloblastoma typically appears as a well-defined mass in the posterior fossa, often in the midline within the cerebellar vermis in children, or more laterally in adults. The tumor may show restricted diffusion on diffusion-weighted imaging, reflecting its high cellularity, and it usually enhances with contrast administration. MRI also provides detailed information about tumor size, location, involvement of surrounding structures, and the presence of leptomeningeal spread, all of which guide surgical planning and treatment decisions.

Central Positional Vertigo in Medulloblastoma

Vertigo is a sensation of movement when no movement is occurring, and it can be classified as peripheral or central in origin. Central positional vertigo arises from dysfunction in the brainstem, cerebellum, or their connections, rather than from the inner ear. Medulloblastoma can cause central positional vertigo when the tumor compresses or invades the vestibular nuclei, cerebellar flocculonodular lobe, or other central pathways that process balance information. Unlike the more common peripheral benign paroxysmal positional vertigo, central positional vertigo often lacks a fatigable response, may be associated with other neurological signs such as ataxia or nystagmus, and the nystagmus itself can be direction-changing or purely vertical. In a patient with a known or suspected posterior fossa tumor, the presence of central positional vertigo is an important clue to the tumor's impact on brain structures.

Diagnosis and Management

Diagnosis of medulloblastoma requires combining clinical evaluation, MRI findings, and ultimately histopathological confirmation through biopsy or surgical resection. Once diagnosed, treatment typically involves maximal safe surgical resection, followed by craniospinal irradiation and chemotherapy, depending on the patient's age and risk stratification. Central positional vertigo and other neurological deficits may improve or resolve with successful tumor treatment, though some patients may experience long-term effects from the tumor or its therapy.